Evidence map›Paper›PMID 38240930›Full record

ArticleInternational urology and nephrology2024

Female ventral-onlay buccal mucosal graft urethroplasty supported with martius labial fat pad flap: early results.

Yavuz Tarik Atik, Burak Uysal, Deniz Gul, Haci Ibrahim Cimen, Huseyin Aydemir, Mehmet Suhha Bostanci, Osman Kose

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yavuz Tarik AtikDepartment of Urology, Sakarya University, Training and Research Hospital, Sakarya, Turkey. yavuztarikatik@gmail.com.ORCID http://orcid.org/0000-0002-6398-8410
Burak UysalFaculty of Medicine, Department of Urology, Sakarya University, Sakarya, Turkey.ORCID http://orcid.org/0000-0002-1816-9029
Deniz GulDepartment of Urology, Sakarya University, Training and Research Hospital, Sakarya, Turkey.ORCID http://orcid.org/0000-0003-0873-0000
Haci Ibrahim CimenFaculty of Medicine, Department of Urology, Sakarya University, Sakarya, Turkey.ORCID http://orcid.org/0000-0002-0824-3926
Huseyin AydemirDepartment of Urology, Sakarya University, Training and Research Hospital, Sakarya, Turkey.ORCID http://orcid.org/0000-0003-4048-7311
Mehmet Suhha BostanciFaculty of Medicine, Department of Gynecology and Obstetrics, Sakarya University, Sakarya, Turkey.ORCID http://orcid.org/0000-0002-4776-6244
Osman KoseFaculty of Medicine, Department of Urology, Sakarya University, Sakarya, Turkey.ORCID http://orcid.org/0000-0002-1053-3551
Sakarya University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThere is a growing interest in reconstructive urology and female urethroplasty. We aimed to report our experience in ventral-onlay buccal mucosa graft (BMG) urethroplasty supported with Martius flap (MF) in treating female urethral stricture disease.

methodsWe retrospectively evaluated data of 18 female patients (ages 35-78) who were diagnosed with urethral stricture disease and underwent ventral-onlay BMG urethroplasty supported with MF by single surgeon in a tertiary referral centre between February 2019 and October 2022. Detailed history, international prostate symptom score (IPSS), pelvic examination, urine flow rate (rate and pattern), post void residual (PVR), storage and voiding phase urodynamic study, and voiding cystourethrography were recorded. At the last visit; the number of urethral dilatations before urethroplasty, time from urethral dilation to urethroplasty, hospital stay, urethral catheterization time, postoperative IPSS, PVR and uroflowmetry values were recorded.

resultsThe presenting symptoms were obstructive voiding symptoms in 16 patients. While the mean number of urethral dilatation was 2.11 ± 1.93 (1-7), the mean time from dilatation to urethroplasty was 5.83 ± 5.00 (1-19 months) months. Maximum flow rate increased from 8.36 ± 3.26 ml/sec in preoperative uroflowmetry to 21.45 ± 5.27 ml/sec at the last follow-up (p < 0.001). Post-void residual urine (PVR) decreased from preoperative mean 116.66 ± 105.88 cc to 26.94 ± 22.69 cc postoperatively (p < 0.004). None of the patients developed stricture recurrence, incontinence or vaginal fistula until the last follow-up. The mean follow-up period was 17.28 ± 11.65 (1-35) months.

conclusionsA ventral-onlay BMG urethroplasty supported with MF represents an effective and reproducible treatment option for FUS in the present study.

Indexed as

Mouth MucosaSurgical FlapsUrethraUrethral StrictureAdipose TissueAdultAgedFemaleHumansMiddle AgedPlastic Surgery ProceduresRetrospective StudiesTime FactorsTreatment OutcomeUrologic Surgical ProceduresVulvaFemaleFlapStrictureUrethroplastyVentral

Identifiers

PMID38240930
OpenAlexW4391032159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.